Draft:Adam Elshaug

• Comment: This contains too much bragging (peacock), please tone it down a lot. It is aldo.more like a CV. Ldm1954 (talk) 15:37, 13 September 2024 (UTC)

---

Professor Adam Elshaug
Adam Elshaug, 2023
Born	1974 (age 49–50) Mount Gambier, Southern Australia
Citizenship	Australian
Academic background
Alma mater	University of South Australia University of Adelaide
Academic work
Discipline	Health services, Policy research

Adam Elshaug (born 1974) is an Australian academic professor and Chair in Health Policy at the University of Melbourne. Born in Mount Gambier, Southern Australia, Elshaug had his BA in Psychology and Sociology from the University of South Australia. He further attended the University of Adelaide, and obtained his BSc.(Hons) in Physiology and a Master of Public Health. He defended his PhD in Health Economics and Policy also from University in 2007.

Career

In 2010, Elshaug was selected as the Commonwealth Fund Harkness Fellow in Health Care Policy and Practice at the Agency for Healthcare Research and Quality.

Elshaug returned to Australia in 2013 and became the Head of the Value in Health Care Division (Lab) and Associate Professor of Healthcare Policy, and was awarded the HCF Research Foundation Principal Research Fellowship, at the Menzies Centre for Health Policy at the University of Sydney. In 2016, he was appointed Professor and became co-director of the Menzies Centre for Health Policy at the University of Sydney.

In 2019-20, Elshaug was a Visiting Fellow at the Economics Studies’ Brookings Schaeffer Initiative for Health Policy at The Brookings Institution in Washington DC. Since 2014, he has been a non-resident Senior Fellow at the Lown Institute in Massachusetts, serving as an economic and policy advisor to Cancer Australia.

In September 2020, Elshaug joined The University of Melbourne as Professor and Chair in Health Policy and Director of the Centre for Health Policy in the Melbourne School of Population and Global Health (MSPGH), also holding a joint Chair appointment in the Melbourne Medical School. He remains an Honorary Professor at the Menzies Centre for Health Policy and Economics at the University of Sydney.

During the first three years of his appointment the Centre for Health Policy expanded significantly, growing from 35 to 130 academic staff and 50 PhD students.

Research and advocacy

Elshaug's research is focused on improving safety and efficiency within health systems, with an emphasis on measuring and mitigating waste, including low-value care, to optimise value in health care utilising administrative health data. His applied policy approach involves collaborating with policy stakeholders to develop and implement reforms aimed at reducing waste and enhancing safety and value in healthcare. This includes crafting and assessing alternative payment models.

Over the past 15 years, Elshaug has served in advisory roles appointed by Australian Labor and Liberal Coalition governments and has been involved in reviewing existing items on the Medicare Schedule through a safety, quality, and value lens, as appointed by multiple Federal Health Ministers and Deputy Secretaries.

Elshaug has been actively enaged in advocacy for reducing low-value care. He has appeared before the Australian Senate Select Committee on Health and participated in various media outlet, including a nationally-televised ABC ‘4 Corners’ 50- minute special titled “Wasted”, which addressed low-value health care in Australia, newspapers, and radio. A 2014 paper co-authored by Elshaug featured in Atul Gwande’s 2015 New Yorker article ‘America’s epidemic of unnecessary care'.

As of March 2023, Elshaug has contributed to securing over AUD$155 million (USD$105 million) in research funding and has received over 200 invitations to speak at international conferences and meetings with government, academic, insurance, and health technology assessment groups.

Select contributions to policy

As of 2024, Elshaug holds or has held several committee and board roles, including:

• Elected as Australia’s representative member of the Scientific Council (SC) of the International Agency for Research on Cancer (IARC), WHO, 2024-2028
• Health Economics and Policy Advisor to Cancer Australia, which includes designing and overseeing economic modelling across the spectrum of cancer care (2014-current)
• Member of the Australian Health Department’s Scope of Practice Review (‘Unleashing the potential of our health workforce’) (2023-2024)
• Member of the Medicare Benefits Schedule Review Advisory Committee (MRAC) at the Australian Commonwealth Department of Health and Aged Care (2021-current)
• Member of the Expert Advisory Committee for Evidence-based Interventions (Academy of Medical Royal Colleges, NHS Clinical Commissioners (NHSCC), the National Institute for Health and Care Excellence (NICE), NHS England and Improvement) (2019-current)
• Member of the Australian Strengthening Medicare Taskforce at the Commonwealth Department of Health. Health Minister as the Chair of Taskforce (2022-2023)
• Member of the Victorian Perioperative Learning Health Network Advisory Group and; Quality and Safety Executive Council, Safer Care Victoria (current)
• Member of the MBS Review Taskforce, including its Principles and Rules Sub-Committee (2015-2020)
• Member of the Health Expert Working Group at the National Australian Broadband Advisory Council (2020-2022)
• Board Director at the New South Wales Bureau of Health Information (2017-2022)
• Elected Member of the Executive Committee of the Health Services Research Association of Australia and New Zealand (HSRAANZ) (2013-2017)

Awards and honours

In 2020, Elshaug received the Health Services Research Association of Australia & New Zealand (HSRAANZ)’s Health Services and Policy Research Impact Award, recognising notable contributions to health services research and policy application in Australia. In 2016, he was part of a team that received Research Australia’s Data Innovation in Health and Medical Research Award. In 2022, Elshaug was a finalist in the Health Services Research Award category at Research Australia’s Health and Medical Research Awards.

Selected academic publications

• Elshaug, A. G., Rosenthal, M. B., Lavis, J. N., Brownlee, S., Schmidt, H., Nagpal, S., Littlejohns, P., Srivastava, D., Tunis, S., Saini, V. (2017). "Levers for addressing medical underuse and overuse: achieving high-quality health care". The Lancet, 390(10090), 191–202. doi:10.1016/S0140-6736(16)32586-7. PMID 28077228.
• Brownless, S., Chalkidou, K., Doust, J., Elshaug, A. G., Glasziou, P., Heath, II., Nagpal, S., Saini, V., Srivastava D., Chalmers, K., Korenstein D. (2017). "Evidence of overuse of medical services around the world". The Lancet, 390(10090), 156-168. doi:10.1016/S0140-6736(16)32585-5. PMID 28077234.
• Badgery-Parker T, Pearson SA, Chalmers K, Brett J, Scott IA, Dunn S, Onley N, Elshaug AG. (2019). "Low-value care in Australian public hospitals: prevalence and trends over time". BMJ quality & safety, 28(3), 205-214. doi:10.1136/bmjqs-2018-008338. PMID 30082331.
• Schwartz, A. L., Landon, B. ., Elshaug, A. G., Chernew, M. E., McWilliams, J. M. (2014). "Measuring low-value care in Medicare". JAMA Internal Medicine, 174(7), 1067-1076. doi:10.1001/jamainternmed.2014.1541. PMID 24819824.
• Parkinson B, Sermet C, Clement F, Crausaz S, Godman B, Garner S, Choudhury M, Pearson SA, Viney R, Lopert R, Elshaug AG. (2015). "Disinvestment and value-based purchasing strategies for pharmaceuticals: an international review". Pharmacoeconomics, 33(9) 905-924. doi:10.1007/s40273-015-0293-8. PMID 26048353.
• Elshaug, A. G., Watt, A. M., Mundy, L., Willis, C. D. (2012). "Over 150 potentially low-value health care practices: an Australian study". Medical Journal of Australia, 197(10), 556-560. doi:10.5694/mja12.11083. PMID 23163685.
• Wade, V. A., Karnon, J., Elshaug, A. G., Hiller J. E. (2010). "A systematic review of economic analyses of telehealth services using real time video communication". BMC Health Services Research, 10, 1-13. doi:10.1186/1472-6963-10-233. PMID 20696073.
• Morgan DJ, Brownlee S, Leppin AL, Kressin N, Dhruva SS, Levin L, Landon BE, Zezza MA, Schmidt H, Saini V, Elshaug AG. (2015). "Setting a research agenda for medical overuse". Bmj, 351. doi:10.1136/bmj.h4534. PMID 26306661.
• Elshaug AG, Moss JR, Littlejohns P, Karnon J, Merlin TL, Hiller JE.(2009). "Identifying existing health care services that do not provide value for money". Medical Journal of Australia, 190(5). doi:10.5694/j.1326-5377.2009.tb02394.x. PMID 19296794.
• Elshaug AG, Hiller JE, Tunis SR, Moss JR. (2007). "Challenges in Australian policy processes for disinvestment from existing, ineffective health care practices". Australia and New Zealand health policy, 4(1). doi:10.1186/1743-8462-4-23. PMID 17973993.

External links

• Google scholar publications